SEC 13F Intelligence

Rtw Investments, LP / RCKT

Rtw Investments, LP’s Rocket Pharmaceuticals Inc Position

Does Rtw Investments, LP own Rocket Pharmaceuticals Inc (RCKT)? Yes — 17.69M shares worth $63M (+0.63% of its 13F portfolio) as of Q1 2026.

Position Value
$63M
Q1 2026
Shares
17.69M
% of Portfolio
+0.63%
Quarters Held
30
currently held

Position History RCKT

Reported value by quarter
Q4 ’18: $236MQ4 ’18Q1 ’19: $280MQ2 ’19: $249MQ3 ’19: $193MQ4 ’19: $383MQ4 ’19Q1 ’20: $235MQ2 ’20: $352MQ3 ’20: $384MQ4 ’20: $936MQ4 ’20Q1 ’21: $697MQ2 ’21: $664MQ3 ’21: $470MQ4 ’21: $345MQ4 ’21Q1 ’22: $251MQ2 ’22: $217MQ3 ’22: $252MQ4 ’22: $346MQ4 ’22Q1 ’23: $303MQ2 ’23: $351MQ3 ’23: $362MQ4 ’23: $530MQ4 ’23Q1 ’24: $477MQ2 ’24: $381MQ3 ’24: $327MQ4 ’24: $222MQ4 ’24Q1 ’25: $118MQ2 ’25: $43MQ3 ’25: $58MQ4 ’25: $62MQ4 ’25Q1 ’26: $63Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202617.69M$63M+0.63%
Q4 202517.69M$62M+0.62%
Q3 202517.69M$58M+0.71%
Q2 202517.69M$43M+0.62%
Q1 202517.69M$118M+1.80%
Q4 202417.69M$222M+3.36%
Q3 202417.69M$327M+4.73%
Q2 202417.69M$381M+5.90%
Q1 202417.69M$477M+7.03%
Q4 202317.69M$530M+8.28%
Q3 202317.69M$362M+7.65%
Q2 202317.69M$351M+6.69%
Q1 202317.69M$303M+6.31%
Q4 202217.69M$346M+7.07%
Q3 202215.80M$252M+5.81%
Q2 202215.80M$217M+5.62%
Q1 202215.80M$251M+5.19%
Q4 202115.80M$345M+5.04%
Q3 202115.80M$470M+7.08%
Q2 202114.99M$664M+10.02%
Q1 202115.72M$697M+10.89%
Q4 202017.06M$936M+15.70%
Q3 202016.81M$384M+9.25%
Q2 202016.81M$352M+9.90%
Q1 202016.81M$235M+10.10%
Q4 201916.81M$383M+14.44%
Q3 201916.59M$193M+11.45%
Q2 201916.59M$249M+13.29%
Q1 201916.04M$280M+19.13%
Q4 201816.04M$236M+21.64%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rtw Investments, LP’s full portfolio or all institutional holders of RCKT.